AI-designed NLRP3 inhibitor receives FDA clearance for Parkinson disease trials

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced that ISM8969, an orally available NLRP3 inhibitor targeting inflammation and neurodegenerative disorders, has recently received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA), intended for the treatment of Parkinson's Disease.

Electrochemotherapy for Cancer Treatment Shows Potential Across Multiple Tumor Types

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

New impulses in local tumor treatment Local control is reaching a new level. In modern oncology, more and more attention is paid to methods that allow effective influence on the tumor without excessive systemic load. Electrochemotherapy for cancer treatment is considered a promising approach for patients with localized or symptomatic lesions. The method combines chemotherapy […]

The post Electrochemotherapy for Cancer Treatment Shows Potential Across Multiple Tumor Types appeared first on Medical News Bulletin.

A Practical Introduction to MRI Systems for Medical Facilities

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Magnetic Resonance Imaging, also known as an MRI, is currently one of the most effective diagnostic tools in the field of medicine. While other kinds of diagnostic equipment use ionizing radiation, an MRI uses magnetic energy and Radio Waves to produce a set of highly intricate graphics detailing tissue in the body. It is because […]

The post A Practical Introduction to MRI Systems for Medical Facilities appeared first on Medical News Bulletin.